Last week, the U.S Treasury Department issued changes to curb corporate inversions. Soon after, Pfizer and Allergan called-off plans for their $160 billion merger. The merger would have shifted the Pfizer headquarters to Ireland, where the firm also would be subject to a lower tax rate. While this was seen as a quick win in …
